Delivery Order SPE2DR25D1053-SPE2DR26FV362
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,429.72 to AmerisourceBergen Drug Corp for the supply of Omnipaque 350 mg/ml infusion bottles (100 ml units). The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of January 12, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,622.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Omnipaque 300 mg/ml infusion bottles (100ml units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,235.01 to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml vials (10 ml) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Omnipaque is a contrast medium used in medical imaging procedures, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,814.91 to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. This non-competitive, firm fixed-price delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $5,239.40 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Omnipaque 300 mg/ml in 100ml infusion bottles. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 15, 2025. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $10,262.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Omnipaque 350 mg/ml intravenous bottles (150 ml units). The contract, awarded on January 8, 2026, with an ultimate completion date of January 9, 2026, represents a non-set-aside competitive procurement executed through the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,140.48 to supply Omnipaque 350 mg/ml Pluspak 500ml, a contrast medium used in medical imaging procedures. The award, issued on January 2, 2026, represents a firm fixed price delivery order with an ultimate completion date of January 5, 2026. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,036.00 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/ml vials (10 ml units). This firm fixed-price, competitively awarded contract was executed on October 29, 2025, with an ultimate completion date of October 30, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $2,705.28 to AmerisourceBergen Drug Corp for Omnipaque 350 mg/mL Pluspak 500mL, a contrast medium used in medical imaging procedures. This firm fixed price delivery order, which became effective on October 28, 2025, with a completion date of October 29, 2025, represents a small-value transaction under AmerisourceBergen's larger contract portfolio with the agency. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,467.90 to supply Omnipaque 300 mg/ml in 30ml containers. The award was made on November 10, 2025, with an ultimate completion date of November 12, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award practices. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV362Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,007.57 to AmerisourceBergen Drug Corp for the supply of Omnipaque 350 mg/ml infusion bottles (100ml) on January 8, 2026, with completion scheduled for January 9, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. Omnipaque is a contrast medium used in medical imaging procedures, reflecting the broad pharmaceutical and medical supply portfolio that AmerisourceBergen provides to federal healthcare systems. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to military healthcare programs worldwide. AmerisourceBergen's demonstrated capability in competing for open federal procurement awards and its established presence as a critical pharmaceutical distributor to the Defense Health Agency and other government healthcare systems underscores its role as a primary vendor for military medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/7/26 |